INSP

Rating buyAI Memo

Inspire Medical

As of 2026-01-16/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-01-16 • Model: RankAlpha Sentiment AI

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

buy

Confidence

medium

Horizon

—

Key catalyst

Next quarterly results / guidance • 2026-04-16

Expected move: +196%

Biggest risk

Reimbursement setbacks, weak adoption, or negative clinical data compress demand and force multiple contraction toward the downside case.

Invalidation

Break below $75 or thesis failure.

What would change my mind?

Faster adoption, broader reimbursement, and positive clinical reads drive revenue growth and multiple expansion toward peer levels.

Research note

Recommendation

buy

Confidence

medium

As of

2026-01-16

Base target

$120

p=60%

Bull target

$170

p=20%

Bear target

$75

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Next quarterly results / guidance
Expanded reimbursement and clinical adoption
Faster adoption, broader reimbursement, and positive clinical reads drive revenue growth and multiple expansion toward peer levels.

BearKey bullets

Competitive pricing or market-share pressure
Negative clinical readouts or safety issues
Reimbursement setbacks or coding losses

WatchKey bullets

ANCHOR: {"price": 95.23, "timestamp_utc": "2026-01-16T18:07:42+00:00", "source": "broker_last"} ANALYST_TARGETS_REVIEWED: true Targets are anchored to the provided market price; the base target sits above the anchor and aligns with median analyst views, the bull is a conservative upside case, and the bear is a stressed downside scenario.

Summary

High-level snapshot

Recommendation

buy

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $120 (p=60%)

Bull/Bear spread: +319% / +85%

Vs latest close: Bull +319% · Base +196% · Bear +85%

Scenario probabilities

Bull Target: $170 (p=20%)Base Target: $120 (p=60%)Bear Target: $75 (p=20%)

Commentary

Market sentiment is mixed: analyst targets are widely dispersed, implying upside in some models but significant disagreement on adoption and reimbursement. Near-term prints and payer signals will likely drive re-rating.

As of 2026-01-16 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Faster adoption, broader reimbursement, and positive clinical reads drive revenue growth and multiple expansion toward peer levels.

Bear Case

Reimbursement setbacks, weak adoption, or negative clinical data compress demand and force multiple contraction toward the downside case.

Drivers

Scannable catalysts and supporting factors

Next quarterly results / guidance
Expanded reimbursement and clinical adoption

Human Analyst Targets

External snippets for comparison only; verify at source.

Unverified externalLast fetched 2026-01-16Source quality: external scrape

External snippets are unverified; treat as directional signals only. Always confirm with the original provider.

Inline RA est

Provider

serper

Median (USD)

$118.08

Range (USD)

$81.81 - $197.00

Count

Query: Inspire Medical Systems Inc Common (INSP) analyst consensus price target high low average

Inspire Medical Systems Inc (INSP) Stock Forecast & Price ...
Search result #1
According to projections from 16 analysts, the average 12-month price target for Inspire Medical Systems is 138.8125, with a high estimate of 180 and a low ...
Open source
Inspire Medical Systems, Inc. (INSP) Stock Price, News, ...
Search result #2
INSPIRE MEDICAL SYSTEMS INC has an Investment Rating of HOLD; a target price of $88.000000; an Industry Subrating of High; a Management Subrating of Low; a ...
Extracted: $88.00Open source
Inspire Medical Systems (INSP) Stock Forecast and Price ...
Search result #3
The highest price target for INSP is $197.00, while the lowest price target for INSP is $85.00.
Extracted: $197.00, $85.00Open source
INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Analyst ...
Search result #4
Analysts have set a mean price target forecast of 144.32. This target is 46.7% above the current price. INSP was analyzed by 25 analysts.
Open source
Inspire Medical Systems (INSP) Price Targets
Search result #5
The forecasts range from a low of $91.00 to a high of $180.00. The average price target represents an increase of 50.83% from the last closing price of $93.05.
Extracted: $91.00, $180.00, $93.05Open source
INSP / Inspire Medical Systems, Inc. (NYSE) - Forecast, ...
Search result #6
The average one-year price target for Inspire Medical Systems, Inc. is $144.32. The forecasts range from a low of $81.81 to a high of $189.00. Read More.
Extracted: $144.32, $81.81, $189.00Open source

Scenarios

Bull Target (Scenario probability)

$170 / p=20% prob

Base Target (Scenario probability)

$120 / p=60% prob

Bear Target (Scenario probability)

$75 / p=20% prob

Price $41 as of 2026-06-02

Nearest Scenario: Bear (∆ 85%)

Targets vs latest close: Bull +319% · Base +196% · Bear +85%

Sentiment & Exposure

Sentiment unavailable: insufficient coverage

Short-term Catalysts

Next few weeks

Next quarterly results / guidance
2026-04-16
Upcoming quarterly results could drive a near-term re-rating if Inspire reports procedure growth and margin beats versus expectations; analyst consensus and targets show material upside range [#SERP-1].
Prob 95% • Move 8% • Priced-in 30%

Long-term Catalysts

Months to a year

Expanded reimbursement and clinical adoption
2027-01-16
Broader payer coverage and increased adoption of hypoglossal nerve stimulation over the next year could materially lift revenue and valuation versus current anchor [#SERP-6].
Prob 55% • Move 60% • Priced-in 40%

Risks

Competitive pricing or market-share pressure
Negative clinical readouts or safety issues
Reimbursement setbacks or coding losses
Slower physician adoption and procedure growth

Peers

Symbol	Summary
RMD	ResMed — global sleep-device leader; benchmark for adoption and reimbursement.
PHG	Philips — major respiratory/sleep competitor influencing share and pricing.
FPH	Fisher & Paykel — respiratory device peer with similar clinical channels.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment AI
Human targets: serper
Targets query: Inspire Medical Systems Inc Common (INSP) analyst consensus price target high low average
Analysis date: 2026-01-16

AI Stock Memo: INSP - Inspire Medical - RankAlpha